Results 281 to 290 of about 38,200 (304)

Modern developments in germline pharmacogenomics for oncology prescribing

Ca-A Cancer Journal for Clinicians, 2022
Natalie Reizine, Peter O'Donnell
exaly  

Pharmacogenomics in Thrombosis

2010
Inherited or acquired genetic abnormalities play a major role in thromboembolic complications. The goal of pharmacogenomics is to tailor medications to an individual's genetic makeup in order to improve the benefit-to-risk ratio. Significant findings have been documented showing the effect of certain genetic variations (e.g., in CYP2C9 and VKORC1) on ...
openaire   +2 more sources

Pharmacogenomics: current status and future perspectives

Nature Reviews Genetics, 2023
Munir Pirmohamed
exaly  

Pharmacogenomics in Children

2014
Historically genetics has not been considered when prescribing drugs for children. However, it is clear that genetics are not only an important determinant of disease in children but also of drug response for many important drugs that are core agents used in the therapy of common problems in children. Advances in therapy and in the ethical construct of
openaire   +2 more sources

A Review of the Important Role of CYP2D6 in Pharmacogenomics

Genes, 2020
Vincent Yip, Richard Turner, Munir Pirmohamed   +2 more
exaly  

Pharmacogenetics and Pharmacogenomics

Pharmacogenomics, 2007
openaire   +3 more sources

Pharmacogenetics and pharmacogenomics of anticancer agents

Ca-A Cancer Journal for Clinicians, 2009
Mark Ratain, R Stephanie Huang
exaly  

Pharmacogenomics of GPCR Drug Targets

Cell, 2018
Sreenivas Chavali, Ikuo Masuho, David E Gloriam   +2 more
exaly  

Hypertension pharmacogenomics: in search of personalized treatment approaches

Nature Reviews Nephrology, 2015
Julie Johnson
exaly  

Evaluation of a Shared Pharmacogenomics Curriculum for Pharmacy Students

Pharmacogenomics, 2015
Kelly C Lee, Joseph Ma
exaly